ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,039.31
-0.47%
Dow Jones
44,713.52
-0.31%
US Dollar vs MXN
20.522
-0.17%
Brent Oil
75.925
-0.89%
Bitcoin
103,515.85
2.15%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. CG Oncology Inc (CGON)

  7. CG Oncology Inc (CGON) Noticias

CGON

CG Oncology (CGON)

CG Oncology Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CGON
FechaHoraFuenteTítuloSímboloCompañía
10/01/202515:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CGONCG Oncology Inc
17/12/202417:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CGONCG Oncology Inc
16/12/202415:05GlobeNewswire Inc.CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CGONCG Oncology Inc
13/12/202415:07Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:CGONCG Oncology Inc
12/12/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CGONCG Oncology Inc
12/12/202419:19GlobeNewswire Inc.CG Oncology Announces Pricing of Public OfferingNASDAQ:CGONCG Oncology Inc
11/12/202415:09Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:CGONCG Oncology Inc
11/12/202405:17GlobeNewswire Inc.CG Oncology Announces Proposed Public OfferingNASDAQ:CGONCG Oncology Inc
06/12/202407:00GlobeNewswire Inc.SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship AwardNASDAQ:CGONCG Oncology Inc
05/12/202406:00GlobeNewswire Inc.Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder CancerNASDAQ:CGONCG Oncology Inc
02/12/202407:00GlobeNewswire Inc.CG Oncology to Host Conference Call and Webcast on BOND-003 Data on Thursday, December 5, 2024NASDAQ:CGONCG Oncology Inc
20/11/202407:00GlobeNewswire Inc.CG Oncology to Present Results on Cretostimogene Grenadenorepvec at the Society of Urologic Oncology (SUO) 25th Annual MeetingNASDAQ:CGONCG Oncology Inc
12/11/202407:00GlobeNewswire Inc.CG Oncology Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:CGONCG Oncology Inc
11/11/202407:00GlobeNewswire Inc.CG Oncology Announces Nature Medicine Publication of Phase 1b Study Results Evaluating Cretostimogene Grenadenorepvec in Combination with Nivolumab in Muscle-Invasive Bladder CancerNASDAQ:CGONCG Oncology Inc
08/11/202413:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CGONCG Oncology Inc
30/08/202407:00GlobeNewswire Inc.CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:CGONCG Oncology Inc
29/08/202419:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CGONCG Oncology Inc
08/08/202407:23GlobeNewswire Inc.CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:CGONCG Oncology Inc
08/08/202405:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CGONCG Oncology Inc
18/06/202407:00GlobeNewswire Inc.CG Oncology Initiates Expanded Access Program for Cretostimogene GrenadenorepvecNASDAQ:CGONCG Oncology Inc
06/06/202411:14GlobeNewswire Inc.CG Oncology Announces Nature Medicine Publication of Final Results from CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive NMIBCNASDAQ:CGONCG Oncology Inc
24/05/202407:00GlobeNewswire Inc.CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenadenorepvec in Combination with Pembrolizumab in BCG-Unresponsive High-Risk NMIBC at ASCO 2024 Annual MeetingNASDAQ:CGONCG Oncology Inc
09/05/202407:00GlobeNewswire Inc.CG Oncology Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:CGONCG Oncology Inc
03/05/202410:23GlobeNewswire Inc.Cretostimogene Monotherapy Demonstrated 75.2% Complete Response Rate in High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder CancerNASDAQ:CGONCG Oncology Inc
26/04/202407:00GlobeNewswire Inc.CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024NASDAQ:CGONCG Oncology Inc
24/04/202409:00GlobeNewswire Inc.CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024NASDAQ:CGONCG Oncology Inc
28/03/202407:00GlobeNewswire Inc.CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual MeetingNASDAQ:CGONCG Oncology Inc
27/02/202407:00GlobeNewswire Inc.CG Oncology Announces First Patient Dosed in PIVOT-006 Phase 3 Clinical Trial of Cretostimogene in Intermediate-risk Non-Muscle Invasive Bladder CancerNASDAQ:CGONCG Oncology Inc
30/01/202406:00Business WireCG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CGONCG Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CGON

Su Consulta Reciente

NYSE
BAC
Bank of America
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
FX
USDMXN
US Dollar vs MXN
COIN
DOGEUSD
Dogecoin
AMEX
XLF
Financial Select Sector
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
NYSE
CVX
Chevron
NYSE
VZ
Verizon Communications
NASDAQ
GOOGL
Alphabet
USOTC
BASFY
BASF (QX)
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios